97706100 - VERSÉA

Information

  • Trademark
  • 97706100
  • Serial Number
    97706100
  • Filing Date
    December 06, 2022
    2 years ago
  • Transaction Date
    November 19, 2024
    a month ago
  • Status Date
    November 19, 2024
    a month ago
  • Published for Opposition Date
    May 28, 2024
    7 months ago
  • Location Date
    November 19, 2024
    a month ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CALLAGHAN, BRIAN
  • Attorney Docket Number
    1358733
    Attorney Name
    Olivia Maria Baratta
    Law Office Assigned Location Code
    L80
  • Owners
Mark Drawing Code
4
Mark Identification
VERSÉA
Case File Statements
  • GS0091: Downloadable mobile applications for use in telemedicine functionalities namely, remotely identifying and assessing health risks and the provision of information about products in the field of healthcare
  • GS0161: Product packaging in the nature of cardboard boxes, plastic and cardboard bags, sheets, and blister packs for packaging; perishables packaging, namely, packaging containers comprised of cardboard for food, beverages, and agricultural products; food packaging, namely, packaging containers comprised of cardboard for food and beverage products
  • GS0051: Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pregnancy testing preparations; ovulation test kits; pH test strips, namely, test strips for use in measuring the pH level in human bodies for purposes of determining levels of alkalinity in the body; diagnostic kits comprised of medical diagnostic test strips for use in disease detection, namely, urinary tract infection; diagnostic kits comprised of medical diagnostic test strips for use in the field of vaginal health; medical diagnostic test strips for use in the field of respiratory and infectious diseases; botanical therapeutic agents for promotion of general wellness; stem cells for medical purposes; pharmaceutical preparations for wounds; vitamins and dietary supplements; natural dietary supplements; dietary and nutritional supplements; mixed biological preparations for the prevention and treatment of infectious diseases; biological tissue cultures for medical purposes; biological bone or skin tissue intended for subsequent implantation; eye care, ophthalmology, and optometry products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, along with reader devices, sold together as a unit; pre-packaged laceration kits comprised of bandages for skin wounds, gauze, and materials to close lacerations; first-aid kits, filled
  • GS0011: Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs
  • GS0441: Healthcare services; healthcare screenings and personalized medicine services
  • GS0101: Medical supplies, namely, sanitary masks for medical wellness purposes, medical gowns, medical apparel, namely, women's garment for use in medical examination and treatment, protective gloves for medical use, medical gloves, gloves for medical purposes, furniture especially made for medical purposes, bracelets for medical purposes, medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate, medical syringes, containers especially adapted for the disposal of medical instruments, syringes and other contaminated medical waste, medical patient treatment chairs, medical ice packs, medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; diagnostic kits consisting primarily of probes, buffers, and reagents for use in disease and microbial testing; medical apparatus for testing blood samples and DNA and RNA samples
  • GS0201: Product packaging in the nature of plastic shipping boxes; perishables packaging, namely, packaging containers of plastic for food, beverages, and agricultural products; food packaging, namely, packaging containers comprised of plastic for food and beverage products; plastic boxes for packaging products
  • GS0421: Medical and scientific research; pharmaceutical research; research, testing, design, and development of pharmaceuticals; research, testing, design, and development of medical devices; research, testing, design, and development of biologics; research, testing, design, and development of product packaging; research, testing, design, and development of perishables packaging; research, testing, design, and development of food packaging; software as a service (SAAS) services, namely, providing a software platform that utilizes machine learning to assess and screen pharmaceutical drug candidates
Case File Event Statements
  • 12/9/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 12/9/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/13/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/15/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/15/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/15/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/30/2023 - a year ago
    7 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/12/2023 - a year ago
    8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 9/12/2023 - a year ago
    9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 12/13/2023 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/13/2023 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/14/2023 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/24/2024 - 11 months ago
    13 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/24/2024 - 11 months ago
    14 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/24/2024 - 11 months ago
    15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/24/2024 - 8 months ago
    16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/24/2024 - 8 months ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/24/2024 - 8 months ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/25/2024 - 8 months ago
    19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/25/2024 - 8 months ago
    20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/25/2024 - 8 months ago
    21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/25/2024 - 8 months ago
    22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/25/2024 - 8 months ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/8/2024 - 7 months ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/28/2024 - 7 months ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/6/2024 - 2 months ago
    28 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 11/19/2024 - a month ago
    29 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/28/2024 - 7 months ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/26/2024 - 6 months ago
    27 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF